简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
06166.HK
CIG SHANGHAI CO., LTD.(06166.HK): Cumulative Deviation of A-share Price Increase Exceeds 20% for Three Consecutive Trading Days; Company States No Undisclosed Matters Requiring Announcement
Tags:
CIG SHANGHAI CO., LTD.
06166.HK
2026-06-25
CIG (06166.HK) plans to issue in total 15.6 million shares by placement, with estimated net proceeds of HKD 1.97 billion
Tags:
CIG
06166.HK
NewTimeSpace
2026-05-28
CIG(06166.HK) closed 13.28% higher on May 19, reached an intraday high of HKD 159.4
Tags:
CIG
06166.HK
NewTimeSpace
2026-05-19
CIG(06166.HK) closed 16.45% lower, the latest market capitalization at HKD 8.57 billion
Tags:
CIG
06166.HK
2026-04-28
CIG(06166.HK) closed 21.08% higher, the latest market capitalization at HKD 11.73 billion
Tags:
CIG
06166.HK
2026-04-22
CIG(06166.HK) closed 10.55% higher, The full-day turnover stood at HKD 2.04 billion
Tags:
CIG
06166.HK
NewTimeSpace
2026-04-21
CIG(06166.HK) closed 34.87% higher, the Hang Seng IT Hardware Sector saw divergent trends
Tags:
CIG
06166.HK
2026-04-17
NewTimeSpace | Supply Chain Dilemma Amidst the AI Wave! Q4 Performance Suddenly Brakes; CIG (06166.HK) Drops Nearly 30% in 2026
Tags:
Cambridge Industries Group
06166.HK
NewTimeSpace
2026-02-28
Featured News
ETF
Csop Ftse Hk-Korea Tech+ Index Etf(03431.HK) Rises 5.74% Intraday with Turnover of HK$56.6191 Million
ETF
Csop Hang Seng China Enterprises Index Daily (2x) Leveraged Product(07288.HK) Rises 6.30% Intraday at HK$2.902
Research
Autonomous Driving Concept Stocks Watch | RoboSense (02498.HK) Edges Up in Morning Session; Second-Generation All-Solid-State Perception Platform E2 Unveiled
Finance
Empowered by HKIC's Patient Capital, Insilico Medicine (3696.HK) Enters $600 Million Global Strategic Partnership with Takeda
Finance
Befar Group(06074.HK): Largest Shareholder Accumulatively Increases Holdings by Approximately 26.38 Million Shares
Finance
Minieye Technology(02431.HK): Proposed H-share Buyback of Up to HK$200 Million
Finance
Xunce (03317.HK): Enters Strategic Cooperation with Xinchen Kechuang
Finance
CanSino Biologics (06185.HK): Supplementary Application for Menhyxin® Accepted, Age Eligibility to Be Expanded to 17 Years Old
Finance
China Wantian Holdings (01854.HK): Enters Strategic Cooperation Framework Agreement with Hengyang Jisuo to Foray into Exoskeleton Robot Sector
Finance
Lee's Pharmaceutical Holdings (00950.HK): Enters Exclusive Licence Agreement with Ashlins for Interferon Alpha-2b for Regions Outside Greater China
Scan QR Code
Download App